Archive for March, 2009

Harvard experts discuss surgical options for benign prostatic hyperplasia

Nancy Ferrari

Senior editor, Harvard Health

Three doctors describe some surgical options for treating an enlarged prostate, including the ones they think patients prefer.

Eating for prostate health: Part 2

Nancy Ferrari

Senior editor, Harvard Health

Post-treatment monitoring

Nancy Ferrari

Senior editor, Harvard Health

PSA testing is not merely a prostate cancer screening tool. After treatment, PSA monitoring is the primary method of measuring treatment success and detecting early signs of cancer recurrence.

Sex and the Prostate: Overcoming erectile dysfunction when you have prostate disease

Nancy Ferrari

Senior editor, Harvard Health

Erectile dysfunction can have many causes, including some forms of prostate disease and prostate cancer surgery. The problem can often be effectively addressed. Some men find relief by taking medications. If these aren’t effective for you, a number of other options, including injections and vacuum devices, are available.

The guide to due diligence in early-stage prostate cancer

Nancy Ferrari

Senior editor, Harvard Health

In a business, due diligence means doing your homework, exploring all the options, and taking reasonable steps to protect yourself. When trying to make a decision about how to treat early-stage prostate cancer, taking time to conduct due diligence is absolutely vital for three reasons:

  • No expert consensus exists about which treatment for early-stage prostate cancer is best (or when treatment is best postponed).

Video: Prostate cancer screening not recommended in men over age 75

Nancy Ferrari

Senior editor, Harvard Health

An authoritative panel concludes that in older men, the PSA blood test causes more problems than benefits.

Video: Disappointing results for Vitamin E and selenium supplements

Nancy Ferrari

Senior editor, Harvard Health

A randomized trial of over 35,000 men shows that vitamin E and selenium supplements fail to reduce the risk of prostate cancer. In this video, Dr. Anthony Komaroff discusses the findings.

Understanding PSA – I_D_2_b_1_b

Nancy Ferrari

Senior editor, Harvard Health

Understanding PSA

Your PSA level is moderately elevated and increasing at a worrisome rate. Follow-up is needed. However, keep in mind that your risk of prostate cancer still less than 40 percent.

Your options include

  • referral to a urologist (prostate specialist)
  • repeat PSA testing in several months
  • measuring your “free” PSA level — This special way of testing your PSA level may help to decide if a biopsy is needed. High levels of free PSA are reassuring, while low levels are worrisome for cancer.

Understanding PSA – I_D_2_b_1_a

Nancy Ferrari

Senior editor, Harvard Health

Understanding PSA

This may be a normal fluctuation in your PSA level. An increase in your PSA of less than 0.75 ng/ml over one year is generally felt to be reassuring. Repeat testing in 3-6 months is a reasonable option. Discuss this with your doctor.


You have reached the end of this guide. What would you like to do?

Understanding PSA – I_D_2_b_1

Nancy Ferrari

Senior editor, Harvard Health

Understanding